title: Ipilimumab has efficacy in metastatic Merkel cell carcinoma: a case series of five patients.
authors.affiliation: Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
authors.forename: J K
authors.initials: JK
authors.lastname: Winkler
authors.affiliation: Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Dimitrakopoulou-Strauss
authors.affiliation: Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Sachpekidis
authors.affiliation: Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Enk
authors.affiliation: Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
authors.forename: J C
authors.initials: JC
authors.lastname: Hassel
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use*; D015266:Carcinoma, Merkel Cell / Q000188:drug therapy* / Q000556:secondary*; D005260:Female; D006801:Humans; D000074324:Ipilimumab / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D000074322:Antineoplastic Agents, Immunological; D000074324:Ipilimumab